36 related articles for article (PubMed ID: 23735828)
1. Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential.
Cozza G; Girardi C; Ranchio A; Lolli G; Sarno S; Orzeszko A; Kazimierczuk Z; Battistutta R; Ruzzene M; Pinna LA
Cell Mol Life Sci; 2014 Aug; 71(16):3173-85. PubMed ID: 24442476
[TBL] [Abstract][Full Text] [Related]
2. PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.
Torres-Ayuso P; Katerji M; Mehlich D; Lookingbill SA; Sabbasani VR; Liou H; Casillas AL; Chauhan SS; Serwa R; Rubin MR; Marusiak AA; Swenson RE; Warfel NA; Brognard J
Cell Chem Biol; 2024 Feb; 31(2):326-337.e11. PubMed ID: 38016478
[TBL] [Abstract][Full Text] [Related]
3. What doesn't fit is made to fit: Pim-1 kinase adapts to the configuration of stilbene-based inhibitors.
Hochban PMM; Heyder L; Heine A; Diederich WE
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2400094. PubMed ID: 38631036
[TBL] [Abstract][Full Text] [Related]
4. Virtual Screening and Design with Machine Intelligence Applied to Pim-1 Kinase Inhibitors.
Schneider P; Welin M; Svensson B; Walse B; Schneider G
Mol Inform; 2020 Sep; 39(9):e2000109. PubMed ID: 33448694
[TBL] [Abstract][Full Text] [Related]
5. Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.
Deslandes S; Chassaing S; Delfourne E
Mar Drugs; 2009 Dec; 7(4):754-86. PubMed ID: 20098609
[TBL] [Abstract][Full Text] [Related]
6. Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.
Blanck S; Geisselbrecht Y; Kräling K; Middel S; Mietke T; Harms K; Essen LO; Meggers E
Dalton Trans; 2012 Aug; 41(31):9337-48. PubMed ID: 22733119
[TBL] [Abstract][Full Text] [Related]
7. Recent synthetic strategies for the construction of functionalized carbazoles and their heterocyclic motifs enabled by Lewis acids.
Kumar MP; G M; Amaladass P; Manikandan C; Dhayalan V
RSC Adv; 2023 Oct; 13(46):32596-32626. PubMed ID: 37936643
[TBL] [Abstract][Full Text] [Related]
8. Carbazole scaffolds in cancer therapy: a review from 2012 to 2018.
Issa S; Prandina A; Bedel N; Rongved P; Yous S; Le Borgne M; Bouaziz Z
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1321-1346. PubMed ID: 31328585
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets.
Shahin R; Swellmeen L; Shaheen O; Aboalhaija N; Habash M
J Comput Aided Mol Des; 2016 Jan; 30(1):39-68. PubMed ID: 26685860
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.
Li YY; Mukaida N
World J Gastroenterol; 2014 Jul; 20(28):9392-404. PubMed ID: 25071334
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of pyrazolo[4,3-a]phenanthridines, a new scaffold for Pim kinase inhibition.
Suchaud V; Gavara L; Giraud F; Nauton L; Théry V; Anizon F; Moreau P
Bioorg Med Chem; 2014 Sep; 22(17):4704-10. PubMed ID: 25087047
[TBL] [Abstract][Full Text] [Related]
12. Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety.
Moreau P; Anizon F; Giraud F; Esvan YJ
Recent Pat Anticancer Drug Discov; 2016; 11(3):309-21. PubMed ID: 27194556
[TBL] [Abstract][Full Text] [Related]
13. PIM kinase inhibitors: Structural and pharmacological perspectives.
Asati V; Mahapatra DK; Bharti SK
Eur J Med Chem; 2019 Jun; 172():95-108. PubMed ID: 30954777
[TBL] [Abstract][Full Text] [Related]
14. Identification of 1,6-dihydropyrazolo[4,3-c]carbazoles and 3,6-dihydropyrazolo[3,4-c]carbazoles as new Pim kinase inhibitors.
Suchaud V; Gavara L; Saugues E; Nauton L; Théry V; Anizon F; Moreau P
Bioorg Med Chem; 2013 Jul; 21(14):4102-11. PubMed ID: 23735828
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
Giraud F; Akué-Gédu R; Nauton L; Candelon N; Debiton E; Théry V; Anizon F; Moreau P
Eur J Med Chem; 2012 Oct; 56():225-36. PubMed ID: 22982527
[TBL] [Abstract][Full Text] [Related]
16. Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives.
Akué-Gédu R; Letribot B; Saugues E; Debiton E; Anizon F; Moreau P
Bioorg Med Chem Lett; 2012 Jun; 22(11):3807-9. PubMed ID: 22543026
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
